[시장보고서]컴퓨터 보조 탐지(CAD) 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 적응증별, 지역별, 부문 예측(2025-2033년)

컴퓨터 보조 탐지(CAD) 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 적응증별, 지역별, 부문 예측(2025-2033년)

Computer Aided Detection Market Size, Share & Trends Analysis Report By Application (Breast Cancer, Lung Cancer, Colon Cancer, Liver Cancer, Neurological Indications), By Indication, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869873

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 190 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

컴퓨터 보조 탐지(CAD) 시장 요약

세계의 컴퓨터 보조 탐지(CAD) 시장 규모는 2024년에 9억 3,660만 달러로 평가되었고, 2033년까지 14억 9,710만 달러에 이를 것으로 예측됩니다.

2025-2033년의 CAGR은 5.19%를 나타낼 전망입니다. 암 발병률 증가와 정기 건강 검진에 대한 인식 제고가 글로벌 컴퓨터 보조 탐지(CAD) 산업의 가장 중요한 성장 촉진요인입니다.

암으로 인한 사망으로 인해 정부와 주요 산업 관계자들은 획기적인 영상 기술을 개발하기 위한 다양한 인식 제고 활동을 펼치고 있습니다. 미국암학회(ACS) 발표에 따르면, 2024년 유방암으로 인한 여성 사망자는 4만 2,250명으로 추정되며, 침습성 유방암 신규 발병 사례는 310,720건에 달합니다. 70세 이상 여성은 전체 유방암 관련 사망자의 50% 이상을 차지했습니다. 암 검출 및 치료에 CAD를 적용하는 것은 시장 성장의 원동력 역할을 합니다.

지난 20년간 암 진단 영상 분야는 놀라운 발전을 이루며 암 연구와 임상 관리에 영향을 미쳤습니다. 담배 흡연은 폐암의 가장 흔한 원인 중 하나이며 미국 내 주요 사망 원인입니다. 또한 예측 기간 동안 흡연으로 인한 여성 사망자 수가 급증할 것으로 예상됩니다. 미국암협회(ACS)에 따르면, 미국 내 사망자 5명 중 1명이 암으로 사망합니다. 이 중 흡연은 전체 암 사망자의 30%, 전체 암 환자의 20%를 차지합니다.

또한 세계보건기구(WHO) 추정치에 따르면, 2022년 기준 암은 전 세계 사망 원인 1위로, 2020년 약 1천만 명(사망자 6명 중 1명꼴)이 암으로 사망했습니다. 암 인식 제고 및 치료 촉진을 위한 정부의 강화된 정책이 시장 성장을 가속화할 것으로 예상됩니다. 예를 들어, 미국 정부는 2022년 2월에 '암 달 착륙 프로젝트(Cancer Moonshot)'을 재시작시켜 향후 25년간 암 사망률을 최소 50% 줄이는 것을 목표로 하고 있습니다.

지역별 시장 점유율 분석(2024년 및 2033년)
지역별 시장 대시보드
세계 지역 시장 현황
시장 규모와 예측 동향 분석(2021-2033년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제7장 경쟁 구도

참가자 개요
기업의 시장 포지셔닝 분석/점유율 분석(2024년)
기업 분류
전략 매핑
기업 프로파일
- EDDA Technology, Inc.
- FUJIFILM Holdings Corporation
- Hologic, Inc.
- Koninklijke Philips NV
- Siemens Healthineers AG
- NANO-X IMAGING LTD.
- CANON MEDICAL SYSTEMS CORPORATION
- GE Healthcare
- IBM
- Riverain Technologies
- iCAD, Inc.
- Median Technologies
- Hitachi, Ltd.
- Shimadzu Analytical(India) Pvt. Ltd
- Carestream Health
- Esaote SPA
- Quibim
- Cleerly
- Planmeca

HBR

영문 목차

영문목차

Computer-Aided Detection Market Summary

The global computer-aided detection market size was estimated at USD 936.6 million in 2024 projected to reach USD 1,497.1 million by 2033, growing at a CAGR of 5.19% from 2025 to 2033. Increasing cancer prevalence and raising awareness for regular health check-ups are the most significant drivers of the global computer-aided detection (CAD) industry.

The deaths due to cancer have led the governments to take various awareness initiatives, along with the key industry contributors, to come up with breakthrough imaging technologies. According to an article published by the American Cancer Society (ACS), 42,250 women deaths from breast cancer were estimated in 2024, with 310,720 new instances of invasive breast cancer. Women aged 70 and over accounted for more than 50% of all breast cancer-related deaths. The applications of CAD in cancer detection and treatment act as a driving force for the market's growth.

Over the last two decades, the diagnostic cancer imaging field has witnessed remarkable evolution and has affected cancer research and clinical management. Tobacco smoking is one of the most common causes of lung cancer and is a leading cause of death in the U.S. Moreover, the number of deaths in women from smoking is expected to increase rapidly over the forecast period. According to ACS, cancer accounted for 1 in 5 deaths in the U.S. Among these, smoking is responsible for 30% of all cancer fatalities and 20% of all cancer cases.

In addition, according to the World Health Organization (WHO) estimates, in 2022, cancer is the leading cause of death worldwide, resulting in approximately 10 million deaths in 2020, or nearly one in six deaths. The enhanced government initiatives to promote cancer awareness and treatment are anticipated to speed up the market's growth. For instance, the U.S. government relaunched the Cancer Moonshot in February 2022, aiming to cut the death rate from cancer by at least 50% over the following 25 years

Global Computer-Aided Detection Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global computer-aided detection market report based on application, indication, and region:

Application Outlook (Revenue, USD Million, 2021 - 2033)
Tuberculosis
Breast cancer
Lung cancer
Colon cancer
Prostate cancer
Liver cancer
Bone cancer
Neurological/Musculoskeletal/Cardiovascular indications
Indication Outlook (Revenue, USD Million, 2021 - 2033)
X-Ray imaging
Computed tomography
Ultrasound imaging
Magnetic resonance
Nuclear medicine imaging
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Application
- 1.1.2. Indication
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Indication outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Computer-Aided Detection Market Variables, Trends & Scope

3.1. Market Dynamics
- 3.1.1. Market driver analysis
  - 3.1.1.1. Rising cancer prevalence
  - 3.1.1.2. Growing regulatory support
  - 3.1.1.3. Technological advancement
- 3.1.2. Market restraint analysis
  - 3.1.2.1. Limited awareness and training
  - 3.1.2.2. High Implementation and Integration Costs
  - 3.1.2.3. Data Privacy and Regulatory Challenges
- 3.1.3. Market opportunity analysis
- 3.1.4. Market challenge analysis
3.2. Computer-Aided Detection Market Analysis Tools
- 3.2.1. Industry Analysis - Porter's 5 Forces Model
  - 3.2.1.1. Supplier power
  - 3.2.1.2. Buyer power
  - 3.2.1.3. Substitution threat
  - 3.2.1.4. Threat of new entrant
  - 3.2.1.5. Competitive rivalry
- 3.2.2. PESTEL Analysis
  - 3.2.2.1. Political landscape
  - 3.2.2.2. Economic landscape
  - 3.2.2.3. Social landscape
  - 3.2.2.4. Technological landscape
  - 3.2.2.5. Environmental landscape
  - 3.2.2.6. Legal landscape
- 3.2.3. Technological Overview
- 3.2.4. Case Study

Chapter 4. Computer-Aided Detection Market: Application Estimates & Trend Analysis

4.1. Application Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Computer-Aided Detection Market by Application Outlook
4.4. Tuberculosis
- 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.5. Breast Cancer
- 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.6. Lung Cancer
- 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.7. Colon/Rectal Cancer
- 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.8. Prostate Cancer
- 4.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.9. Liver Cancer
- 4.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.10. Bone Cancer
- 4.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.11. Neurological/Musculoskeletal/Cardiovascular Indications
- 4.11.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Computer-Aided Detection Market: Indication Estimates & Trend Analysis

5.1. Indication Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Computer-Aided Detection Market by Indication Outlook
5.4. X-Ray Imaging
- 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.5. Computed Tomography
- 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.6. Ultrasound Imaging
- 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.7. Magnetic Resonance Imaging
- 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.8. Nuclear Medicine Imaging
- 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.9. Others
- 5.9.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Computer-Aided Detection Market: Regional Estimates & Trend Analysis, By Application, By Indication

6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.5. North America
- 6.5.1. U.S.
  - 6.5.1.1. Key country dynamics
  - 6.5.1.2. Regulatory framework
  - 6.5.1.3. Competitive scenario
  - 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5.2. Canada
  - 6.5.2.1. Key country dynamics
  - 6.5.2.2. Regulatory framework
  - 6.5.2.3. Competitive scenario
  - 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5.3. Mexico
  - 6.5.3.1. Key country dynamics
  - 6.5.3.2. Regulatory framework
  - 6.5.3.3. Competitive scenario
  - 6.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Europe
- 6.6.1. UK
  - 6.6.1.1. Key country dynamics
  - 6.6.1.2. Regulatory framework
  - 6.6.1.3. Competitive scenario
  - 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.2. Germany
  - 6.6.2.1. Key country dynamics
  - 6.6.2.2. Regulatory framework
  - 6.6.2.3. Competitive scenario
  - 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.3. France
  - 6.6.3.1. Key country dynamics
  - 6.6.3.2. Regulatory framework
  - 6.6.3.3. Competitive scenario
  - 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.4. Italy
  - 6.6.4.1. Key country dynamics
  - 6.6.4.2. Regulatory framework
  - 6.6.4.3. Competitive scenario
  - 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.5. Spain
  - 6.6.5.1. Key country dynamics
  - 6.6.5.2. Regulatory framework
  - 6.6.5.3. Competitive scenario
  - 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.6. Norway
  - 6.6.6.1. Key country dynamics
  - 6.6.6.2. Regulatory framework
  - 6.6.6.3. Competitive scenario
  - 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.7. Sweden
  - 6.6.7.1. Key country dynamics
  - 6.6.7.2. Regulatory framework
  - 6.6.7.3. Competitive scenario
  - 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6.8. Denmark
  - 6.6.8.1. Key country dynamics
  - 6.6.8.2. Regulatory framework
  - 6.6.8.3. Competitive scenario
  - 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Asia Pacific
- 6.7.1. Japan
  - 6.7.1.1. Key country dynamics
  - 6.7.1.2. Regulatory framework
  - 6.7.1.3. Competitive scenario
  - 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7.2. China
  - 6.7.2.1. Key country dynamics
  - 6.7.2.2. Regulatory framework
  - 6.7.2.3. Competitive scenario
  - 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7.3. India
  - 6.7.3.1. Key country dynamics
  - 6.7.3.2. Regulatory framework
  - 6.7.3.3. Competitive scenario
  - 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7.4. Australia
  - 6.7.4.1. Key country dynamics
  - 6.7.4.2. Regulatory framework
  - 6.7.4.3. Competitive scenario
  - 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7.5. South Korea
  - 6.7.5.1. Key country dynamics
  - 6.7.5.2. Regulatory framework
  - 6.7.5.3. Competitive scenario
  - 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7.6. Thailand
  - 6.7.6.1. Key country dynamics
  - 6.7.6.2. Regulatory framework
  - 6.7.6.3. Competitive scenario
  - 6.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Latin America
- 6.8.1. Brazil
  - 6.8.1.1. Key country dynamics
  - 6.8.1.2. Regulatory framework
  - 6.8.1.3. Competitive scenario
  - 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 6.8.2. Argentina
  - 6.8.2.1. Key country dynamics
  - 6.8.2.2. Regulatory framework
  - 6.8.2.3. Competitive scenario
  - 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.9. MEA
- 6.9.1. South Africa
  - 6.9.1.1. Key country dynamics
  - 6.9.1.2. Regulatory framework
  - 6.9.1.3. Competitive scenario
  - 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 6.9.2. Saudi Arabia
  - 6.9.2.1. Key country dynamics
  - 6.9.2.2. Regulatory framework
  - 6.9.2.3. Competitive scenario
  - 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 6.9.3. UAE
  - 6.9.3.1. Key country dynamics
  - 6.9.3.2. Regulatory framework
  - 6.9.3.3. Competitive scenario
  - 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 6.9.4. Kuwait
  - 6.9.4.1. Key country dynamics
  - 6.9.4.2. Regulatory framework
  - 6.9.4.3. Competitive scenario
  - 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Participant Overview
7.2. Company Market Position Analysis/ Share Analysis (2024)
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
- 7.5.1. EDDA Technology, Inc.
  - 7.5.1.1. Company overview
  - 7.5.1.2. Financial performance
  - 7.5.1.3. Product benchmarking
  - 7.5.1.4. Strategic initiatives
- 7.5.2. FUJIFILM Holdings Corporation
  - 7.5.2.1. Company overview
  - 7.5.2.2. Financial performance
  - 7.5.2.3. Product benchmarking
  - 7.5.2.4. Strategic initiatives
- 7.5.3. Hologic, Inc.
  - 7.5.3.1. Company overview
  - 7.5.3.2. Financial performance
  - 7.5.3.3. Product benchmarking
  - 7.5.3.4. Strategic initiatives
- 7.5.4. Koninklijke Philips N.V
  - 7.5.4.1. Company overview
  - 7.5.4.2. Financial performance
  - 7.5.4.3. Product benchmarking
  - 7.5.4.4. Strategic initiatives
- 7.5.5. Siemens Healthineers AG
  - 7.5.5.1. Company overview
  - 7.5.5.2. Financial performance
  - 7.5.5.3. Product benchmarking
  - 7.5.5.4. Strategic initiatives
- 7.5.6. NANO-X IMAGING LTD.
  - 7.5.6.1. Company overview
  - 7.5.6.2. Financial performance
  - 7.5.6.3. Product benchmarking
  - 7.5.6.4. Strategic initiatives
- 7.5.7. CANON MEDICAL SYSTEMS CORPORATION
  - 7.5.7.1. Company overview
  - 7.5.7.2. Financial performance
  - 7.5.7.3. Product benchmarking
  - 7.5.7.4. Strategic initiatives
- 7.5.8. GE Healthcare
  - 7.5.8.1. Company overview
  - 7.5.8.2. Financial performance
  - 7.5.8.3. Product benchmarking
  - 7.5.8.4. Strategic initiatives
- 7.5.9. IBM
  - 7.5.9.1. Company overview
  - 7.5.9.2. Financial performance
  - 7.5.9.3. Product benchmarking
  - 7.5.9.4. Strategic initiatives
- 7.5.10. Riverain Technologies
  - 7.5.10.1. Company overview
  - 7.5.10.2. Financial performance
  - 7.5.10.3. Product benchmarking
  - 7.5.10.4. Strategic initiatives
- 7.5.11. iCAD, Inc.
  - 7.5.11.1. Company overview
  - 7.5.11.2. Financial performance
  - 7.5.11.3. Product benchmarking
  - 7.5.11.4. Strategic initiatives
- 7.5.12. Median Technologies
  - 7.5.12.1. Company overview
  - 7.5.12.2. Financial performance
  - 7.5.12.3. Product benchmarking
  - 7.5.12.4. Strategic initiatives
- 7.5.13. Hitachi, Ltd.
  - 7.5.13.1. Company overview
  - 7.5.13.2. Financial performance
  - 7.5.13.3. Product benchmarking
  - 7.5.13.4. Strategic initiatives
- 7.5.14. Shimadzu Analytical (India) Pvt. Ltd
  - 7.5.14.1. Company overview
  - 7.5.14.2. Financial performance
  - 7.5.14.3. Product benchmarking
  - 7.5.14.4. Strategic initiatives
- 7.5.15. Carestream Health
  - 7.5.15.1. Company overview
  - 7.5.15.2. Financial performance
  - 7.5.15.3. Product benchmarking
  - 7.5.15.4. Strategic initiatives
- 7.5.16. Esaote SPA
  - 7.5.16.1. Company overview
  - 7.5.16.2. Financial performance
  - 7.5.16.3. Product benchmarking
  - 7.5.16.4. Strategic initiatives
- 7.5.17. Quibim
  - 7.5.17.1. Company overview
  - 7.5.17.2. Financial performance
  - 7.5.17.3. Product benchmarking
  - 7.5.17.4. Strategic initiatives
- 7.5.18. Cleerly
  - 7.5.18.1. Company overview
  - 7.5.18.2. Financial performance
  - 7.5.18.3. Product benchmarking
  - 7.5.18.4. Strategic initiatives
- 7.5.19. Planmeca
  - 7.5.19.1. Company overview
  - 7.5.19.2. Financial performance
  - 7.5.19.3. Product benchmarking
  - 7.5.19.4. Strategic initiatives

한글목차

컴퓨터 보조 탐지(CAD) 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 컴퓨터 보조 탐지 시장의 변수, 동향, 범위

제4장 컴퓨터 보조 탐지 시장 : 용도별 추정 및 동향 분석

제5장 컴퓨터 보조 탐지 시장 : 적응증별 추정 및 동향 분석

제6장 컴퓨터 보조 탐지 시장 : 지역별 추정 및 동향 분석, 용도별, 적응증별